ALLISON HOWER: Open Payments
NPI 1801367867 · RICHBORO, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,991 in 86 payments from 20 companies in 2025. Trend: 2023 $1,170 · 2024 $1,301 · 2025 $1,991
Food & beverage: $1,991
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $325 |
| ABBVIE INC. | 17 | $310 |
| Otsuka America Pharmaceutical, Inc. | 8 | $268 |
| AstraZeneca Pharmaceuticals LP | 4 | $170 |
| Sumitomo Pharma America, Inc. | 5 | $126 |
| Lilly USA, LLC | 6 | $125 |
| PFIZER INC. | 4 | $95 |
| Almatica Pharma LLC | 4 | $92 |
| Exact Sciences Corporation | 4 | $90 |
| Axsome Therapeutics, Inc. | 3 | $68 |
Products named: REXULTI, AIRSUPRA, UBRELVY, VRAYLAR, GEMTESA, MOUNJARO, LOREEV XR, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
